These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 21520230

  • 1. The complex world of oligodendroglial differentiation inhibitors.
    Kremer D, Aktas O, Hartung HP, Küry P.
    Ann Neurol; 2011 Apr; 69(4):602-18. PubMed ID: 21520230
    [Abstract] [Full Text] [Related]

  • 2. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE, Kuhlmann T, Antel JP.
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [Abstract] [Full Text] [Related]

  • 3. Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.
    Nakahara J, Aiso S, Suzuki N.
    Expert Opin Ther Targets; 2009 Dec; 13(12):1375-86. PubMed ID: 19839715
    [Abstract] [Full Text] [Related]

  • 4. [Oligodendrocytes have a key role in the development of CNS function and in myelin related diseases].
    Anderson ES, Bjartmar C.
    Lakartidningen; 2000 Jul 12; 97(28-29):3265-8. PubMed ID: 10997013
    [Abstract] [Full Text] [Related]

  • 5. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
    Van Strien ME, Baron W, Bakker EN, Bauer J, Bol JG, Brevé JJ, Binnekade R, Van Der Laarse WJ, Drukarch B, Van Dam AM.
    Glia; 2011 Nov 12; 59(11):1622-34. PubMed ID: 21818782
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of remyelination: recent insight from experimental models.
    Tanaka T, Yoshida S.
    Biomol Concepts; 2014 Aug 12; 5(4):289-98. PubMed ID: 25372760
    [Abstract] [Full Text] [Related]

  • 7. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS, Blakemore WF.
    Adv Exp Med Biol; 1999 Aug 12; 468():183-97. PubMed ID: 10635029
    [Abstract] [Full Text] [Related]

  • 8. Axon-oligodendrocyte interactions during developmental myelination, demyelination and repair.
    Piaton G, Gould RM, Lubetzki C.
    J Neurochem; 2010 Sep 01; 114(5):1243-60. PubMed ID: 20524961
    [Abstract] [Full Text] [Related]

  • 9. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA, Akirav EM.
    J Neurosci Res; 2015 May 01; 93(5):687-96. PubMed ID: 25287108
    [Abstract] [Full Text] [Related]

  • 10. Do central nervous system axons remyelinate?
    Nait-Oumesmar B, Lachapelle F, Decker L, Baron-Van Evercooren A.
    Pathol Biol (Paris); 2000 Feb 01; 48(1):70-9. PubMed ID: 10729914
    [Abstract] [Full Text] [Related]

  • 11. Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation.
    Wang Y, Piao JH, Larsen EC, Kondo Y, Duncan ID.
    J Neurosci Res; 2011 Nov 01; 89(11):1737-46. PubMed ID: 21793039
    [Abstract] [Full Text] [Related]

  • 12. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
    Jadasz JJ, Aigner L, Rivera FJ, Küry P.
    Cell Tissue Res; 2012 Jul 01; 349(1):331-47. PubMed ID: 22322424
    [Abstract] [Full Text] [Related]

  • 13. Regulation of oligodendrocyte differentiation and myelination.
    Emery B.
    Science; 2010 Nov 05; 330(6005):779-82. PubMed ID: 21051629
    [Abstract] [Full Text] [Related]

  • 14. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W.
    Glia; 1999 Oct 05; 28(1):34-9. PubMed ID: 10498820
    [Abstract] [Full Text] [Related]

  • 15. Activation of oligodendroglial Stat3 is required for efficient remyelination.
    Steelman AJ, Zhou Y, Koito H, Kim S, Payne HR, Lu QR, Li J.
    Neurobiol Dis; 2016 Jul 05; 91():336-46. PubMed ID: 27060559
    [Abstract] [Full Text] [Related]

  • 16. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
    Pfeifenbring S, Metz I, Kremer D, Küry P, Hartung HP, Brück W.
    Glia; 2013 Aug 05; 61(8):1250-60. PubMed ID: 23828667
    [Abstract] [Full Text] [Related]

  • 17. Teriflunomide promotes oligodendroglial differentiation and myelination.
    Göttle P, Manousi A, Kremer D, Reiche L, Hartung HP, Küry P.
    J Neuroinflammation; 2018 Mar 13; 15(1):76. PubMed ID: 29534752
    [Abstract] [Full Text] [Related]

  • 18. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO.
    Adv Exp Med Biol; 2017 Mar 13; 958():91-127. PubMed ID: 28093710
    [Abstract] [Full Text] [Related]

  • 19. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
    Islam MS, Tatsumi K, Okuda H, Shiosaka S, Wanaka A.
    Neurochem Int; 2009 Mar 13; 54(3-4):192-8. PubMed ID: 19070638
    [Abstract] [Full Text] [Related]

  • 20. The cellular and molecular events of central nervous system remyelination.
    Dubois-Dalcq M, Armstrong R.
    Bioessays; 1990 Dec 13; 12(12):569-76. PubMed ID: 2080911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.